Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Bulletin Du Cancer
|
June 4, 2005
[Anemia and cancer]
Jean-Philippe Spano, Moise Namer
Bulletin Du Cancer
|
June 20, 2017
Florence Joly, Denis Querleu, Moise Namer, et al.
Bulletin Du Cancer
|
February 21, 2004
[Neoadjuvant endocrine therapy for breast cancer: an overview]
Julien Domont, Moise Namer, David Khayat, et al.
Critical Reviews in Oncology/Hematology
|
August 19, 2007
Novel therapeutic strategies combining antihormonal and biological targeted therapies in breast cancer: focus on clinical trials and perspectives
Joseph Gligorov, David Azria, Moise Namer, et al.
Journal of Human Genetics
|
June 27, 2003
A mutation analysis of the BRCA1 gene in 140 families from southeast France with a history of breast and/or ovarian cancer
Philippe Rostagno, Jeanine Gioanni, Eliane Garino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 18, 2004
Breast cancer with synchronous metastases: trends in survival during a 14-year period
Fabrice Andre, Khemaies Slimane, Thomas Bachelot, et al.
Clinical Breast Cancer
|
December 31, 2005
The global breast cancer burden: variations in epidemiology and survival
Gabriel N Hortobagyi, Jaime de la Garza Salazar, Kathleen Pritchard, et al.
Bulletin Du Cancer
|
December 7, 2023
Recommandations francophones pour la pratique clinique concernant la prise en charge des cancers du sein de Saint-Paul-de-Vence 2022-2023
Joseph Gligorov, Marc-Antoine Benderra, Xavier Barthere, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 7, 2019
Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumours: guidelines from the French national network dedicated to rare gynaecological cancers
Christine Rousset-Jablonski, Fréderic Selle, Elodie Adda-Herzog, et al.
Bulletin Du Cancer
|
February 6, 2018
[Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumors: Guidelines from the French national network dedicated to rare gynaecological cancer]
Christine Rousset-Jablonski, Fréderic Selle, Elodie Adda-Herzog, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Bulletin Du Cancer
|
June 4, 2005
[Anemia and cancer]
Jean-Philippe Spano, Moise Namer
Bulletin Du Cancer
|
June 20, 2017
Florence Joly, Denis Querleu, Moise Namer, et al.
Bulletin Du Cancer
|
February 21, 2004
[Neoadjuvant endocrine therapy for breast cancer: an overview]
Julien Domont, Moise Namer, David Khayat, et al.
Critical Reviews in Oncology/Hematology
|
August 19, 2007
Novel therapeutic strategies combining antihormonal and biological targeted therapies in breast cancer: focus on clinical trials and perspectives
Joseph Gligorov, David Azria, Moise Namer, et al.
Journal of Human Genetics
|
June 27, 2003
A mutation analysis of the BRCA1 gene in 140 families from southeast France with a history of breast and/or ovarian cancer
Philippe Rostagno, Jeanine Gioanni, Eliane Garino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 18, 2004
Breast cancer with synchronous metastases: trends in survival during a 14-year period
Fabrice Andre, Khemaies Slimane, Thomas Bachelot, et al.
Clinical Breast Cancer
|
December 31, 2005
The global breast cancer burden: variations in epidemiology and survival
Gabriel N Hortobagyi, Jaime de la Garza Salazar, Kathleen Pritchard, et al.
Bulletin Du Cancer
|
December 7, 2023
Recommandations francophones pour la pratique clinique concernant la prise en charge des cancers du sein de Saint-Paul-de-Vence 2022-2023
Joseph Gligorov, Marc-Antoine Benderra, Xavier Barthere, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 7, 2019
Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumours: guidelines from the French national network dedicated to rare gynaecological cancers
Christine Rousset-Jablonski, Fréderic Selle, Elodie Adda-Herzog, et al.
Bulletin Du Cancer
|
February 6, 2018
[Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumors: Guidelines from the French national network dedicated to rare gynaecological cancer]
Christine Rousset-Jablonski, Fréderic Selle, Elodie Adda-Herzog, et al.
Page
of 2